We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TNGX market cap is 161.08M. The company's latest EPS is USD -1.2053 and P/E is -1.20.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.43M | 6.47M | 19.88M | 11.61M | 4.12M |
| Operating Income | -35.01M | -42.26M | -29.55M | -32.88M | -40.91M |
| Net Income | -30.76M | -37.91M | -25.55M | -29.17M | -37.67M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 37.04M | 24.86M | 36.53M | 42.07M |
| Operating Income | -181k | -58.19M | -111.07M | -114.17M | -145.6M |
| Net Income | -123k | -58.24M | -108.18M | -101.74M | -130.3M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 402.57M | 406.22M | 381.45M | 352.42M | 316.49M |
| Total Liabilities | 149.46M | 141.77M | 133.78M | 123.25M | 116.98M |
| Total Equity | 253.11M | 264.45M | 247.67M | 229.17M | 199.52M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 168.31M | 500.16M | 436.47M | 402.57M | 316.49M |
| Total Liabilities | 5.95M | 155.41M | 186.99M | 149.46M | 116.98M |
| Total Equity | 5M | 344.75M | 249.48M | 253.11M | 199.52M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -117.98M | -37.86M | -61.46M | -94.85M | -131.5M |
| Investing | 41.43M | -11.2M | 1.5M | 34.07M | 86.13M |
| Financing | 82.41M | 42.98M | 44.29M | 46.7M | 47.66M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -328k | -59.53M | -109.08M | -117.98M | -131.5M |
| Investing | -166.75M | -183.43M | 26.4M | 41.43M | 86.13M |
| Financing | 168.39M | 357.33M | 1.62M | 82.41M | 47.66M |
| Market Cap | 161.08M |
| Price to Earnings Ratio | -1.20 |
| Price to Sales Ratio | 3.73 |
| Price to Cash Ratio | 2.25 |
| Price to Book Ratio | 0.79 |
| Dividend Yield | - |
| Shares Outstanding | 108.11M |
| Average Volume (1 week) | 647.26k |
| Average Volume (1 Month) | 665.15k |
| 52 Week Change | -80.00% |
| 52 Week High | 12.015 |
| 52 Week Low | 1.11 |
| Spread (Intraday) | 0.08 (5.33%) |
| Company Name | Tango Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.tangotx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
